Era Taoufik

127 Vassilissis Sofias Avenue
Athens, ESYE31 11521, Greece

Last Updated: 09/26/2026

Save publications for later

Sign Up

Not sure about your diagnosis?

Check Your Symptoms

Found 14 publications

Dysregulated proteostasis in p.A53T-α-Synuclein astrocytes aggravates Lewy-like neuropathology in a Parkinson's disease iPSC model.

Dysregulated proteostasis in p.A53T-α-Synuclein astrocytes aggravates Lewy-like neuropathology in a Parkinson's disease iPSC model.

Journal: Proceedings of the National Academy of Sciences of the United States of America

Published: November 17, 2025

G6PD deficiency triggers dopamine loss and the initiation of Parkinson's disease pathogenesis.

G6PD deficiency triggers dopamine loss and the initiation of Parkinson's disease pathogenesis.

Journal: Cell reports

Published: September 14, 2024

Early Signs of Molecular Defects in iPSC-Derived Neural Stems Cells from Patients with Familial Parkinson's Disease.

Early Signs of Molecular Defects in iPSC-Derived Neural Stems Cells from Patients with Familial Parkinson's Disease.

Journal: Biomolecules

Published: May 11, 2022

Organoids: the third dimension of human brain development and disease.

Organoids: the third dimension of human brain development and disease.

Journal: The International journal of developmental biology

Published: December 09, 2021

High content screening and proteomic analysis identify a kinase inhibitor that rescues pathological phenotypes in a patient-derived model of Parkinson's disease.

High content screening and proteomic analysis identify a kinase inhibitor that rescues pathological phenotypes in a patient-derived model of Parkinson's disease.

Journal: NPJ Parkinson's disease

Published: April 08, 2021

Patient-Derived Induced Pluripotent Stem Cell-Based Models in Parkinson's Disease for Drug Identification.

Patient-Derived Induced Pluripotent Stem Cell-Based Models in Parkinson's Disease for Drug Identification.

Journal: International journal of molecular sciences

Published: August 31, 2020

Pharmacological intervention in a transgenic mouse model improves Alzheimer's-associated pathological phenotype: Involvement of proteasome activation.

Pharmacological intervention in a transgenic mouse model improves Alzheimer's-associated pathological phenotype: Involvement of proteasome activation.

Journal: Free radical biology & medicine

Published: July 24, 2020

Clusterin overexpression in mice exacerbates diabetic phenotypes but suppresses tumor progression in a mouse melanoma model.

Clusterin overexpression in mice exacerbates diabetic phenotypes but suppresses tumor progression in a mouse melanoma model.

Journal: Aging

Published: June 11, 2020

Engraftable Induced Pluripotent Stem Cell-Derived Neural Precursors for Brain Repair.

Engraftable Induced Pluripotent Stem Cell-Derived Neural Precursors for Brain Repair.

Journal: Methods in molecular biology (Clifton, N.J.)

Published: June 01, 2020

In Vivo Phenotyping of Familial Parkinson's Disease with Human Induced Pluripotent Stem Cells: A Proof-of-Concept Study.

In Vivo Phenotyping of Familial Parkinson's Disease with Human Induced Pluripotent Stem Cells: A Proof-of-Concept Study.

Journal: Neurochemical research

Published: November 26, 2018

Synaptic dysfunction in neurodegenerative and neurodevelopmental diseases: an overview of induced pluripotent stem-cell-based disease models.

Synaptic dysfunction in neurodegenerative and neurodevelopmental diseases: an overview of induced pluripotent stem-cell-based disease models.

Journal: Open biology

Published: March 22, 2018

Bioinformatically Informed Design of Synthetic Mammalian Promoters.

Bioinformatically Informed Design of Synthetic Mammalian Promoters.

Journal: Methods in molecular biology (Clifton, N.J.)

Published: August 13, 2017

Showing 1-12 of 14

Last Updated: 09/26/2026